Drug Type Biological products |
Synonyms HL 190, HL-190 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetic Retinopathy | Preclinical | Japan | - | |
| Diabetic Retinopathy | Preclinical | South Korea | - | |
| Diabetic Retinopathy | Preclinical | South Korea | - | |
| Uveitis | Preclinical | Japan | - | |
| Uveitis | Preclinical | South Korea | - | |
| Uveitis | Preclinical | South Korea | - | |
| Wet Macular Degeneration | Preclinical | Japan | - | |
| Wet Macular Degeneration | Preclinical | South Korea | - | |
| Wet Macular Degeneration | Preclinical | South Korea | - |





